Amanote Research
Register
Sign In
Pioglitazone May Reduce Cardiovascular Events in High Risk Patients With Prediabetes
British Medical Journal
- United Kingdom
doi 10.1136/bmj.i1087
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
February 22, 2016
Authors
Unknown
Publisher
BMJ
Related search
Optimal Blood Pressure Goals in Patients With Hypertension at High Risk for Cardiovascular Events
Journal of Hypertension- Open Access
Rosiglitazone and Pioglitazone Utilization From January 2007 Through May 2008 Associated With Five Risk-Warning Events
Journal of Managed Care Pharmacy
P2-390 Cardiovascular and Diabetes Risk in Persons With Prediabetes
Journal of Epidemiology and Community Health
Epidemiology
Public Health
Occupational Health
Environmental
Hypertriglyceridemia Is Associated With Long-Term Risk of Cardiovascular Events and Specific Comorbidity in Very High-Risk Hypertensive Patients
Ukrainian Biochemical Journal
Biochemistry
Detecting Pioglitazone Use and Risk of Cardiovascular Events Using Electronic Health Record Data in a Large Cohort of Chinese Patients With Type 2 Diabetes
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Risk of Major Cardiovascular Events in Patients With Type 2 Diabetes With and Without Prior Cardiovascular Events: Results From the Leader Trial
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
The Role of Niacin in Raising High-Density Lipoprotein Cholesterol to Reduce Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and Optimally Treated Low-Density Lipoprotein Cholesterol
American Heart Journal
Cardiovascular Medicine
Cardiology
Depression and Risk of Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease
The Bangkok Medical Journal
